Fundies.
English

ACURA PHARMACEUTICALS, INC

EDGAR
ACUR Current report (8-K) · filed 2026-01-20

126 filing records in this dataset, filed from 1996-05-15 to 2026-01-20. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

270 thousand Unit_Standard_USD_3bSdTirTbUSgGCsk-U777A

2021 Q3 · Unit_Standard_USD_3bSdTirTbUSgGCsk-U777A

Exact inputs and evidence
  • Revenue: 270000 Unit_Standard_USD_3bSdTirTbUSgGCsk-U777A Source

Operating margin

-196.67%

2021 Q3 · %

Exact inputs and evidence
  • Operating Income: -531000 Unit_Standard_USD_3bSdTirTbUSgGCsk-U777A Source
  • Revenue: 270000 Unit_Standard_USD_3bSdTirTbUSgGCsk-U777A Source
Cash and cash equivalents
95 thousand Unit1 Source
Exact value

95000 Unit1

Long-term debt including current maturities
4.65 million Unit1 Source
Exact value

4647000 Unit1

Shares outstanding
65.1 million Unit_Standard_shares_vIvycFfUS0efOexttaMByg Source
Exact value

65093000 Unit_Standard_shares_vIvycFfUS0efOexttaMByg

Reported share-count change

200.66% · 43.4 million Unit_Standard_shares_vIvycFfUS0efOexttaMByg

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 21650000 Unit_Standard_shares_vIvycFfUS0efOexttaMByg · 2020-12-31· Source
  • 65093000 Unit_Standard_shares_vIvycFfUS0efOexttaMByg · 2021-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Capital expenditure

0 USD

2017-01-01 – 2017-12-31

Exact inputs and evidence
  • Capital expenditure: 0 USD · 2017-01-01 – 2017-03-31 Source
  • Capital expenditure: 0 USD · 2017-01-01 – 2017-06-30 Source
  • Capital expenditure: 0 USD · 2017-01-01 – 2017-03-31 Source
  • Capital expenditure: 0 USD · 2017-01-01 – 2017-09-30 Source
  • Capital expenditure: 0 USD · 2017-01-01 – 2017-06-30 Source
  • Capital expenditure: 0 USD · 2017-01-01 – 2017-12-31 Source
  • Capital expenditure: 0 USD · 2017-01-01 – 2017-09-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-01-20.

Financial data available through: 2021-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure
  • Revenue: 2 of 11 periods available· newest 2021-12-31
  • Operating income: 2 of 11 periods available· newest 2021-12-31
  • Net income: 2 of 11 periods available· newest 2021-12-31
  • Operating cash flow: 2 of 11 periods available· newest 2021-12-31
  • Capital expenditure: 7 of 11 periods available· newest 2017-12-31
  • Total assets: 2 of 11 periods available· newest 2021-12-31
  • Total liabilities: 2 of 11 periods available· newest 2021-12-31
  • Current assets: 2 of 11 periods available· newest 2021-12-31
  • Current liabilities: 2 of 11 periods available· newest 2021-12-31
  • Cash and cash equivalents: 2 of 11 periods available· newest 2018-12-31
  • Long-term debt including current maturities: 1 of 11 periods available· newest 2018-12-31
  • Shares outstanding: 2 of 11 periods available· newest 2021-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    -56.2%

    Prior period

    Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g 3.57 million

    –

    Current period

    Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g 1.56 million

    –

    Exact inputs and evidence

    1563000 − 3570000 = -2007000 Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g

    3570000 Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g · 2020-01-01 – 2020-12-31

    Inspect prior input Prior source

    1563000 Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g · 2021-01-01 – 2021-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g 329,000

    Prior period

    −Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g 1.21 million

    –

    Current period

    −Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g 879,000

    –

    Exact inputs and evidence

    -879000 − -1208000 = 329000 Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g

    -1208000 Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g · 2020-01-01 – 2020-12-31

    Inspect prior input Prior source

    -879000 Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g · 2021-01-01 – 2021-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g 23,000

    Prior period

    −Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g 719,000

    –

    Current period

    −Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g 742,000

    –

    Exact inputs and evidence

    -742000 − -719000 = -23000 Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g

    -719000 Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g · 2020-01-01 – 2020-12-31

    Inspect prior input Prior source

    -742000 Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g · 2021-01-01 – 2021-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2021 2021-01-01 – 2021-12-31

  • Revenue Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g 1.56 million 100% of revenue
  • Operating costs Derived Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g 2.78 million 178% of revenue
  • Operating income −Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g 1.21 million −78% of revenue
  • Tax, interest and other Derived −Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g 335,000 −21% of revenue
  • Net income −Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g 879,000 −56% of revenue

Cash

  • Operating cash flow −Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g 742,000 −47% of revenue
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2020 Operating loss: operating costs were 121% of revenue.
  • 2021 Operating loss: operating costs were 178% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2020 2020-01-01 – 2020-12-313570000 4328000 Derived -758000 450000 Derived -1208000 Unavailable
Source
2021 2021-01-01 – 2021-12-311563000 2777000 Derived -1214000 -335000 Derived -879000 Unavailable
Source

Amounts are exact, in Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g 1.6M 2021
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.3.9M2.9M1.9M963.9K0.020202021
Values and sources
Revenue values and source evidence
PeriodSeriesValue(Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g)Source evidence
2020Revenue3570000
2021Revenue1563000

Revenue growth

Change in revenue from the same financial period one year earlier.

-56.2% 2021
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.4%-12%-28%-44%-61%20202021
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2020Year over yearNo prior comparable period
2021Year over year-56.2%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -77.7% 2021
Net margin -56.2% 2021
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.6%-16%-39%-61%-84%20202021
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2020Operating margin-21.2%
2021Operating margin-77.7%
2020Net margin-33.8%
2021Net margin-56.2%
2020Free cash flow marginNot reported
2021Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g -742K 2021
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.59.4K-155.8K-371.0K-586.2K-801.4K20202021
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g)Source evidence
2020Operating cash flow-719000
2021Operating cash flow-742000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g)Source evidence
2020Free cash flowUnavailable
2021Free cash flowUnavailable

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

79.3% 2021
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.474%356%237%119%0%20202021
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2020Liabilities / assets439.3%
2021Liabilities / assets79.3%

Current assets to current liabilities

Current assets divided by current liabilities.

0.72× 2021
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.0.78×0.59×0.39×0.20×0.00×20202021
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2020Current assets / current liabilities0.16×
2021Current assets / current liabilities0.72×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2020 2020-01-01 – 2020-12-31
−Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g 1.21 million
Exact value

Exact value: -1208000 Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g

2020-01-01 – 2020-12-31: -1208000 Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g 719,000
Exact value

Exact value: -719000 Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g

2020-01-01 – 2020-12-31: -719000 Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2021 2021-01-01 – 2021-12-31
−Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g 879,000
Exact value

Exact value: -879000 Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g

2021-01-01 – 2021-12-31: -879000 Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g 742,000
Exact value

Exact value: -742000 Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g

2021-01-01 – 2021-12-31: -742000 Unit_Standard_USD_VsNzc0bxX0Ka3I05VXq24g Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

126 filings · 3,730 latest values · 3,730 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0000786947, 786947, ACUR, acur, edgar:786947

Also known as ACURA PHARMACEUTICALS, INC, ACURA PHARMACEUTICALS, INC., ACURA PHARMACEUTICALS, INC, Acura Pharmaceuticals, Inc, HALSEY DRUG CO INC/NEW